Table 3.
Number of patients in the study cohort with CVD outcomes of interest by outcome subtype
| MI | Stroke | Heart failure | ||||
| MICAD | MINOCA | Embolic | Ischaemic | Haemorrhagic | ||
| PPCM (n=558) | <10* | <10* | <10* | <10* | 0 | 56 |
| Chronic HTN (n=12 458) | 14 | <10* | <10* | 28 | <10* | 152 |
| Gestational HTN (n=43 073) | <10* | <10* | <10* | 22 | <10* | 188 |
| Pre-eclampsia (n=56 419) | 16 | <10 | <10 | 60 | 14 | 355 |
| Chronic HTN and gestational HTN (n=4907) | <10* | 0 | <10* | <10* | <10* | 45 |
| Chronic HTN and pre-eclampsia (n=5743) | <10* | 0 | <10* | 35 | <10* | 135 |
| Gestational DM (n=107 636) | 24 | <10* | 12 | 62 | 29 | 320 |
| Preterm birth (n=116 768) | 42 | 15 | 13 | 96 | 25 | 532 |
| IUGR (n=23 504) | <10* | <10* | <10* | 17 | <10* | 86 |
| Total | 126 | 40 | 53 | 333 | 91 | 1251 |
*In accordance with HCUP policies, categories in which there were fewer than 10 patients are represented simply as <10.
CVD, cardiovascular disease; DM, diabetes mellitus;HCUP, Healthcare Cost and Utilization Project; HTN, hypertension;IUGR, intrauterine growth restriction; MI, myocardial infarction;MICAD, MI with obstructive coronary artery disease;MINOCA, MI without obstructive coronary artery disease;PPCM, peripartum cardiomyopathy.